RMTG CEO discusses uplisting path to Nasdaq
Regenerative Medical Technology Group Inc. (RMTG) executives discussed Q1 2026 revenue growth and the strategic process required for a potential Nasdaq listing, while acknowledging current liabilities from business growth.
View filing at SEC.gov →